Recombinant factor VIII Fc fusion protein drives regulatory macrophage polarization

The main complication of replacement therapy with factor in hemophilia A (HemA) is the formation of inhibitors (neutralizing anti–factor VIII [FVIII] antibodies) in ∼30% of severe HemA patients. Because these inhibitors render replacement FVIII treatment essentially ineffective, preventing or elimin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood Adv
Hauptverfasser: Kis-Toth, Katalin, Rajani, Gaurav Manohar, Simpson, Allison, Henry, Kate L., Dumont, Jennifer, Peters, Robert T., Salas, Joe, Loh, Christine
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2018
Schlagworte:
Immunobiology and Immunotherapy
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6234359/
https://ncbi.nlm.nih.gov/pubmed/30396910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018024497
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge